CCO Expert Recap

Gastrointestinal Cancer: Expert Recap

Source: CCO Independent Conference Coverage of the 2008 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Gastrointestinal Cancer: Expert Recap

Program Director: Ramaswamy Govindan, MD

Faculty:

John L. Marshall, MD

CREDIT INFORMATION

Release Date: July 31, 2008

Expiration Date: July 30, 2009

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the role of KRAS mutations in epidermal growth factor receptor–targeted therapies for patients with colorectal cancer
Describe recent clinical trial results related to adjuvant chemotherapy in colorectal cancer
Explain the efficacy of dual antibody therapy in the treatment of refractory and frontline metastatic colorectal cancer
Review the role of positron emission tomography in patient selection for surgical resection of metastatic colorectal cancer

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.